FHD-286 |
| Catalog No.GC64821 |
FHD-286 es un inhibidor de ATPasa BRG1/BRM para el tratamiento de trastornos relacionados con BAF, como la leucemia mieloide aguda.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2671128-05-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
FHD-286 is a BRG1/BRM ATPase inhibitor for the treatment of BAF-related disorders such as acute myeloid leukemia.
[1]. Centore, Richard C. et al. Preparation of BRG1/BRM inhibitors for treating cancer. US20220079940 A1.
Review for FHD-286
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for FHD-286
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *